The formation and performance of auxetic textiles. Part I: theoretical and technical considerations

Auxetic textiles belong to a class of extraordinary materials that become fatter when stretched. Sustained efforts to fabricate auxetic fabric structures are limited. Indeed, several geometrical configurations have been previously proposed but none has been engineered into functional auxetic textile fabrics. The use of auxetic materials has been limited because of problems with deploying them in their fabricated forms. Our thrust in this research is to combine our knowledge of geometry and fabric structural characteristics to engineer auxetic textiles and to determine the properties of such auxetic textile fabrics. In this paper, we have presented the technique we developed for producing several knit structures in which filling yarn inlays are used to effect compound repeating units. In these productions, the chain is used as a base structure and a minimum of two guide bars and maximum of six guide bars are deployed to produce such warp knit auxetic fabrics.     

FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies

Simple SummaryTargeting of CD40 with antibodies attracts significant translational interest. While inhibitory CD40 targeting appears particularly attractive in the field of organ transplantation and for the treatment of autoimmune diseases, stimulatory CD40 targeting is the aim in tumor immunotherapy and vaccination against infectious pathogens. It turned out that lack of FcγR-binding is the crucial factor for the development of safe and well-tolerated inhibitory anti-CD40 antibodies. In striking contrast, FcγR-binding is of great importance for the CD40 stimulatory capacity of the majority of anti-CD40 antibodies. Typically, anti-CD40 antibodies only robustly stimulate CD40 when presented by FcγRs. However, FcγR-binding of anti-CD40 antibodies also triggers unwanted activities such as destruction of CD40 expressing cells by ADCC or ADCP. Based on a brief discussion of the mechanisms of CD40 activation, we give an overview of the ongoing activities in the development of anti-CD40 antibodies under special consideration of attempts aimed at the development of anti-CD40 antibodies with FcγR-independent agonism or FcγR subtype selectivity.AbstractInhibitory targeting of the CD40L-CD40 system is a promising therapeutic option in the field of organ transplantation and is also attractive in the treatment of autoimmune diseases. After early complex results with neutralizing CD40L antibodies, it turned out that lack of Fcγ receptor (FcγR)-binding is the crucial factor for the development of safe inhibitory antibodies targeting CD40L or CD40. Indeed, in recent years, blocking CD40 antibodies not interacting with FcγRs, has proven to be well tolerated in clinical studies and has shown initial clinical efficacy. Stimulation of CD40 is also of considerable therapeutic interest, especially in cancer immunotherapy. CD40 can be robustly activated by genetically engineered variants of soluble CD40L but also by anti-CD40 antibodies. However, the development of CD40L-based agonists is biotechnologically and pharmacokinetically challenging, and anti-CD40 antibodies typically display only strong agonism in complex with FcγRs or upon secondary crosslinking. The latter, however, typically results in poorly developable mixtures of molecule species of varying stoichiometry and FcγR-binding by anti-CD40 antibodies can elicit unwanted side effects such as antibody-dependent cellular cytotoxicity (ADCC) or antibody-dependent cellular phagocytosis (ADCP) of CD40 expressing immune cells. Here, we summarize and compare strategies to overcome the unwanted target cell-destroying activity of anti-CD40-FcγR complexes, especially the use of FcγR type-specific mutants and the FcγR-independent cell surface anchoring of bispecific anti-CD40 fusion proteins. Especially, we discuss the therapeutic potential of these strategies in view of the emerging evidence for the dose-limiting activities of systemic CD40 engagement.     

The wine and beer yeast Dekkera bruxellensis

Recently, the non‐conventional yeast Dekkera bruxellensis has been gaining more and more attention in the food industry and academic research. This yeast species is a distant relative of Saccharomyces cerevisiae and is especially known for two important characteristics: on the one hand, it is considered to be one of the main spoilage organisms in the wine and bioethanol industry; on the other hand, it is 'indispensable' as a contributor to the flavour profile of Belgium lambic and gueuze beers. Additionally, it adds to the characteristic aromatic properties of some red wines. Recently this yeast has also become a model for the study of yeast evolution. In this review we focus on the recently developed molecular and genetic tools, such as complete genome sequencing and transformation, to study and manipulate this yeast. We also focus on the areas that are particularly well explored in this yeast, such as the synthesis of off‐flavours, yeast detection methods, carbon metabolism and evolutionary history. © 2014 The Authors. Yeast published by John Wiley & Sons, Ltd.     

C60 fullerene enhances cisplatin anticancer activity and overcomes tumor cell drug resistance

We formulated and analyzed a novel nanoformulation of the anticancer drug cisplatin (Cis) with C60 fullerene (C60+Cis complex) and showed its higher toxicity toward tumor cell lines in vitro when compared to Cis alone.The highest toxicity of the complex was observed in HL-60/adr and HL-60/vinc chemotherapyresistant human leukemia cell sublines (resistant to Adriamycin and Vinculin,respectively).We discovered that the action of the C60+Cis complex is associated with overcoming the drug resistance of the tumor cell lines through observing an increased number of apoptotic cells in the Annexin V/PI assay.Moreover,in vivo assays with Lewis lung carcinoma (LLC) C57BL/6J male mice showed that the C60+Cis complex increases tumor growth inhibition,when compared to Cis or C60 fullerenes alone.Simultaneous1y,we conducted a molecular docking study and performed an Ames test.Molecular docking specifies the capability of a C60 fullerene to form van der Waals interactions with potential binding sites on P-glycoprotein (P-gp),multidrug resistance protein 1 (MRP-1),and multidrug resistance protein 2 (MRP-2) molecules.The observed phenomenon revealed a possible mechanism to bypass tumor cell drug resistance by the C,o+Cis complex.Additionally,the results of the Ames test show that the formation of such a complex diminishes the Cis mutagenic activity and may reduce the probability of secondary neoplasm formation.In conclusion,the C60+Cis complex effectively induced tumor cell death in vitro and inhibited tumor growth in vivo,overcoming drug resistance likely by the potential of the C60 fullerene to interact with P-gp,MRP-1,and MRP-2 molecules.Thus,the C60+Cis complex might be a potential novel chemotherapy modification.     

Evaluation of electrokinetic removal of heavy metals from sewage sludge

The presence of heavy metals is one of the main obstacles for agricultural use of million tonnes of dewatered sewage sludge produced in wastewater treatment plants. Electrokinetic (EK) treatment can be applied to remove heavy metals from sludge. The aim of this study was to increase the efficiency of electrokinetic removal of heavy metals from dewatered sewage sludge. EK experiments were carried out with and without pH adjustment in cathode chamber of acidified sewage sludge. The selective sequential extraction (SSE) was used to determine the fractionation of heavy metals in sewage sludge. The mobility of heavy metals in sludge significantly increased after its acidification at pH 2.7 and followed the order: Ni, Zn, Cu, As, Cr, Pb. Removal efficiencies of heavy metals in the experiment with acidified sewage sludge and pH adjustment at cathode chamber at 2.0 were: 95% for Zn, 96% for Cu, 90% for Ni, 68% for Cr, 31% for As and 19% for Pb. The concentrations of Zn, Cu, Ni, Cr and Pb after EK treatment were below the United States Environmental Protection Agency limits for biosolids applied to agricultural land, forest, public contact sites or reclamation sites.     

Integration of low-grade heat from exhaust gases into energy system of the enterprise

Clean Technologies and Environmental Policy - The paper presents a Process Integration application for waste heat utilisation from exhaust gas streams with partial condensation. It is based on the...     

Highly Emissive and Electrochemically Stable Thienylene Vinylene Oligomers and Copolymers: An Unusual Effect of Alkylsulfanyl Substituents

The synthesis, unexpected efficient photoluminescence, and reversible electrochemical p‐ and n‐doping of new conjugated thienylene vinylene materials functionalized with alkylsulfanyl substituents poly(trithienylene vinylene) (PTTV) and poly(dithienylvinyl‐co‐benzothiadiazole) (PDTVB) along with dithienylvinylene‐based oligomers is reported. The materials are studied by thermal and X‐ray diffraction analysis, optical spectroscopy, cyclic voltammetry, and spectroelectrochemistry. Organic field‐effect transistors (OFETs) are fabricated with PTTV and PDTVB. The polymers, prepared by Stille polycondensation, exhibit good thermal stability and a photoluminescent quantum yield in the range 34%–68%. Low bandgaps (1.5–1.8 eV), estimated by optical and electrochemical measurements along with high stability of both redox states, suggest that these structures are promising materials for photovoltaic applications. OFETs fabricated with PDTVB reveal a hole mobility of 7 × 10^?3 cm² V^?1 s^?1 with on/off ratio 10⁵, which are comparatively high values for completely amorphous polymer semiconductors.     

A simple and sensitive method for determination of vitamins D3 and K1 in rat plasma: application for an in vivo pharmacokinetic study

Purpose: To develop and to validate a simple but sensitive method for determination of vitamins D₃ and K₁ in rat plasma.

Methods: The sample treatment included protein precipitation by cold acetonitrile, evaporation, reconstitution with methanol and filtration. The chromatography conditions included Xterra RP18 3.5?µm 4.6?×?100?mm column at ambient temperature and mobile phase consisting of methanol/water (93/7, v/v) at 0.5?mL/min flow rate. Vitamin D₃ and probucol were detected at 265?nm and vitamin K₁ at 239?nm. Rats were administered intravenously by 0.1?mg/kg of vitamin D₃ or K₁ and the blood samples were withdrawn pre-administration and at pre-determined time points post-administration. The pharmacokinetic analysis was performed using a non-compartmental approach.

Results: The calibration curves in rat plasma were linear up to 5000?ng/mL for both vitamins. The limit of quantification (LOQ) was 20?ng/mL for vitamin D₃ and 40?ng/mL for K₁. Inter- and intra-day precision and accuracy were below 15%. The pharmacokinetic parameters of vitamin D₃ following intravenous administration were: AUC_0?∞?=?11323?±?1081?h?×?ng/mL, V_d?=?218?±?80?mL/kg, CL?=?8.9?±?0.8?mL/h/kg, t_1/2?=?16.8?±?5?h; and of vitamin K₁: AUC_0?∞?=?2495?±?297?h?×?ng/mL, V_d?=?60?±24?mL/kg, CL?=?40.5?±?5.1?mL/h/kg, t_1/2?=?1.1?±0.5?h.

Conclusion: The developed HPLC–UV assay is a simple and sensitive method for the determination of vitamins D₃ and K₁ in rat plasma. A higher dose of vitamin K₁ should be used in future studies for accurate estimation of pharmacokinetic parameters. The data show the suitability of the assay for pharmacokinetic studies in rats.